Although PFS was also lower in the p53-mut/null group than in the p53-wt group, the difference was not statistically significant (Figure 6), highlighting that TP53 genetic status may be a more reliable prognostic marker in DLBCL (Supplementary Figure S3). Here, TP53 is linked to diffuse large B-cell lymphoma.